Laura Vela-Martín

4PUBLICATIONS
19CO-AUTHORS
Haematological tumoursSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 20, 2024
PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL.

Antonio Lahera, Laura Vela-Martín, Pablo Fernández-Navarro

|Jun 02, 2023
Comprehensive characterization of a novel, oncogenic and targetable SEPTIN6::ABL2 fusion in T-ALL.

Antonio Lahera, Laura Vela-Martín, Pilar López-Nieva

|Feb 14, 2023
SOCS3 deregulation contributes to aberrant activation of the JAK/STAT pathway in precursor T-cell neoplasms.

Antonio Lahera, Pilar López-Nieva, Hernán Alarcón

|Dec 11, 2022
A Dual Role for FADD in Human Precursor T-Cell Neoplasms.

José Luis Marín-Rubio, Laura Vela-Martín, Jack Gudgeon

Pageof 1